Objectives: We aimed to use an artificial intelligence (AI)-based pleural effusion segmentation model on baseline 18F-FDG positron emission tomography/computed tomography (PET/CT) images to investigate the prognostic value of PET/CT-derived parameters for overall survival (OS) among lung cancer patients with malignant pleural effusion (MPE).
Methods: A total of 146 patients with MPEs were recruited. An integrated AI segmentation model combining 3D spatially weighted and 2D classical U-Net segmented pleural effusion for 18F-FDG PET/CT parameter extraction. Cox regression analyses revealed independent 12-month survival predictors. The area under the receiver operating characteristic curve (AUC) and DeLong's test were used to evaluate the discriminant power of the predictors and the LENT score. Bootstrap resampling was employed for internal validation.
Results: The patients comprised 81 males (55.5%) and had a mean age of 61.7 (SD = 11.5) years. The key survival predictors included maximum standardised uptake value (SUVmax), metabolic tumour volume (MTV), and total lesion glycolysis (TLG). The combined PET/CT parameters demonstrated a statistically significant advantage over that of the LENT score for 12-month survival prediction (AUC: 0.849, 95% confidence interval (CI) 0.795-0.903 vs. AUC: 0.732, 95%CI 0.660-0.796). The internal bootstrap validation had an AUC of 0.840 (95% CI: 0.671-0.922) and demonstrated a well-fitting calibration curve.
Conclusions: The baseline 18F-FDG-PET/CT parameters extracted using the deep learning model performed excellent in predicting MPE survival and may complement existing MPE survival models and guide clinical stratified treatment.
Advances in knowledge: AI-integrated 18F-FDG-PET/CT radiomics improved prognostic assessment of MPE, facilitating personalised interventions stratified by survival expectations.
Keywords: 18F-FDG PET/CT; artificial intelligence; machine learning; malignant pleural effusion; prognostic factor.
© The Author(s) 2026. Published by Oxford University Press on behalf of the British Institute of Radiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.